November 8, 2017 / 10:11 PM / 16 days ago

BRIEF-CRISPR Therapeutics announces third quarter results

Nov 8 (Reuters) - CRISPR Therapeutics AG

* CRISPR Therapeutics announces third quarter 2017 financial results and provides business update

* CRISPR Therapeutics ag qtrly net ‍loss per share attributable to common shareholders​ of $0.62 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below